Search

Your search keyword '"Windecker, S."' showing total 1,862 results

Search Constraints

Start Over You searched for: Author "Windecker, S." Remove constraint Author: "Windecker, S."
1,862 results on '"Windecker, S."'

Search Results

2. Effect of alirocumab on quantitative flow ratio and diameter stenosis in non-infarct related arteries from patients with acute myocardial infarction: a PACMAN-AMI randomized clinical trial substudy

3. Interleukin-6 plasma levels are elevated in patients with acute myocardial infarction and predict death or recurrent infarction within 1 year - a case-control study

5. Frequency, predictors and clinical outcomes of AMI patients with triple regression of coronary atherosclerosis: A sub-analysis of the PACMAN AMI trial

7. In patients with acute myocardial infarction interleukin-8 levels are related to impaired renal function and predict recurrent infarction or death at 1-year follow-up - a case-control study

8. Association between quantitative flow ratio and non-target-vessel-related events before planned staged percutaneous coronary intervention in patients with acute coronary syndrome

9. Effect of evolocumab on platelet function in patients with acute coronary syndromes. An analysis of the randomized, double-blind, placebo-controlled EVOPACS Trial

13. Three-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomised Controlled Trial (Amulet IDE)

14. Twenty-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalized in Switzerland.

15. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry

21. Interrelation between baseline plaque characteristics and changes in coronary atherosclerosis with the PCSK9-inhibitor alirocumab: insights from the PACMAN-AMI randomized trial

22. Impact of alirocumab added to high-intensity statin therapy on platelet function in AMI patients: a pre-specified substudy of the randomized, placebo-controlled PACMAN-AMI trial

24. Heavy weekly alcohol consumption versus binge drinking after an acute coronary syndrome and risk of major adverse cardiovascular events at one year follow up

25. Outcomes of patients presenting with acute coronary syndromes on workdays vs. rest days (SPUM-ACS substudy)

26. Effect of alirocumab added to high-Intensity statin therapy on endothelial function in patients with acute myocardial infarction: a sub-study of the randomized placebo-controlled PACMAN-AMI trial

28. Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention : insights from the GLOBAL LEADERS trial

29. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis

30. Functional Status After Transcatheter and Surgical Aortic Valve Replacement: 2-Year Analysis From the SURTAVI Trial

34. Effect of Evolocumab on Changes in Coronary Plaque Phenotype in Statin-Treated Patients Following Myocardial Infarction: The HUYGENS Randomised Clinical Trial

35. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis The Task Force for the management of COVID-19 of the European Society of Cardiology

36. Frequency and prognostic impact of periprocedural myocardial infarction determined by various MI definitions in patients with chronic coronary syndromes undergoing percutaneous coronary intervention

38. Impact of smoking cessation on depression after acute coronary syndrome

42. Comparison of risk prediction models in infarct-related cardiogenic shock

45. Temporal trends in the treatment and outcomes of elderly patients with acute coronary syndrome

46. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

47. Predictors of Outcomes Following Transcatheter Edge-to-Edge Mitral Valve Repair

48. Infective Endocarditis After Transcatheter Aortic Valve Replacement

49. 2019 ESC Guidelines for themanagement of patients with supraventricular tachycardia

50. 2020 EAPCI core curriculum for percutaneous cardiovascular interventions

Catalog

Books, media, physical & digital resources